why choose us

300×250 Ad Slot

Research Article: Summary of Research: An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: A Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study

Date Published: 2024-01-08

Introduction:
This is a summary of the original article “An Anti-OX40 Antibody to Treat Moderate-to-Severe Atopic Dermatitis: a Multicentre, Double-Blind, Placebo-Controlled Phase 2b Study” [1] (Fig. 1).

Read more

300×250 Ad Slot